These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24802885)

  • 1. Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls.
    Kawamura K; Ichikado K; Suga M; Yoshioka M
    Respiration; 2014; 87(6):478-84. PubMed ID: 24802885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study.
    Kawamura K; Ichikado K; Yasuda Y; Anan K; Suga M
    BMC Pulm Med; 2017 Jun; 17(1):94. PubMed ID: 28629448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
    Mikamo H; Iwasaku K; Yamagishi Y; Matsumizu M; Nagashima M
    J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of outcome after acute exacerbation of idiopathic interstitial pneumonia].
    Tsukamoto K; Chida K; Hayakawa H; Sato A; Nakajima Y; Doi O; Yamaguchi T; Taguchi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jul; 35(7):746-54. PubMed ID: 9341279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.
    Saiman L; Mayer-Hamblett N; Anstead M; Lands LC; Kloster M; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    Pediatr Pulmonol; 2012 Jul; 47(7):641-8. PubMed ID: 22684984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combined therapy with cyclosporin and low-dose prednisolone in interstitial pneumonia associated with connective tissue disease.
    Watanabe N; Sakamoto K; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Ono K; Fukuoka J; Nishiyama O; Hasegawa Y
    Respiration; 2014; 87(6):469-77. PubMed ID: 24576910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
    Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
    Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
    Sato T; Teramukai S; Kondo H; Watanabe A; Ebina M; Kishi K; Fujii Y; Mitsudomi T; Yoshimura M; Maniwa T; Suzuki K; Kataoka K; Sugiyama Y; Kondo T; Date H;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1604-1611.e3. PubMed ID: 24267779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
    Asai N; Ohkuni Y; Iwasaki T; Matsunuma R; Nakashima K; Otsuka Y; Kaneko N
    J Infect Chemother; 2011 Dec; 17(6):793-8. PubMed ID: 21633810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation].
    Faber M; Jahnz-Rózyk K; Targowski T; Mamełka B
    Pol Merkur Lekarski; 2003 Jan; 14(79):36-8. PubMed ID: 12712826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
    LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
    Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oral azithromycin in chronic plaque psoriasis: a controlled trial.
    Saxena VN; Dogra J
    Eur J Dermatol; 2010; 20(3):329-33. PubMed ID: 20299307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
    Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
    Jorgensen DM
    Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.